About

Sources of Support

From 2008 to 2013, Harvard Catalyst was supported by a five-year, $117.5 million Clinical and Translational Science Award (8UL1TR000170-05 and 8KL2TR000168-05) from the National Center for Advancing Translational Science (NCATS) at the National Institutes of Health, with additional support from partner institutions. In 2013, Harvard Catalyst was awarded a five-year Clinical and Translational Science Award (1UL1 TR001102-01). In 2018, Harvard Catalyst was awarded a five-year Clinical and Translational Science Award (UL1TR002541).

In 2023, Harvard Catalyst was awarded a seven-year Clinical and Translational Science Award (UM1TR004408) with additional funding over seven years from:

• Harvard Medical School
• Harvard T.H. Chan School of Public Health
• Beth Israel Deaconess Medical Center
• Boston Children’s Hospital
• Brigham and Women’s Hospital
• Dana-Farber Cancer Institute
• Massachusetts General Hospital